Give us a brief about Ignite Life Science Foundation - the story of its origin, its goal and target audience, etc.
Ignite was launched formally at an event in January 2020 but its story had begun prior to that. It is the brainchild of Professor Ramaswamy Subramanian, who was at that time heading C-CAMP in Bengaluru - a part of the Bangalore biocluster. During his working years in India, he recognised many problems Indian scientists were facing and it was not simply a matter of quantum of funding; there were multiple factors.
Research productivity thrives in a complex ecosystem. Very few countries in the world have succeeded in building such self-sustaining ecosystems consisting of multiple factors -government funding, academic institutions (that are often private) that consider research an important purpose for their existence, ability to attract the best students from the global pool, private philanthropists willing to support science through large endowments and the co-existence of research universities with communities of investors, start-ups and large company R&D facilities The Boston-Cambridge (Harvard) area and the San Francisco Bay Area (Stanford), Cambridge University (Cambridge, UK) and the Stockholm area (Stockholm University) are some examples.
Building out such ecosystems takes time, but Rams and his scientific peers got together with leading business persons and academics in India to find Ignite as an organisation that would nurture good science using philanthropic money. Connecting uHNIs to science in Indian universities is the first step towards getting widespread acknowledgement of the challenges facing Indian science and pooling resources and capabilities to solve some of these challenges - funding is only one among those.
この記事は Express Pharma の July 2021 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Express Pharma の July 2021 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation